Jefferies has published a report on UnitedHealth Group UNH raising the price target to $62.00 from $60.00.
In the report, Jefferies wrote, "We recommend buying UNH, especially on weakness. 2Q was very solid with the company beating EPS by 11% and raising FY11 guidance 5% (in line with consensus). Admittedly, the bar was high, but UNH's 250bps share price underperformance yesterday is a bit of a head-scratcher. Our thesis is further supported by affirmation of growth pointing higher than current out-year estimates. We are raising our price target $2 to $62."
Jefferies rated UnitedHealth Group a BUY with a price target of $62.00. UnitedHealth Group closed Tuesday at $51.45.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareJefferiesManaged Health CareUnitedHealth Group
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in